Blockchain Registration Transaction Record

Aclarion Secures AI Patent to Revolutionize Chronic Back Pain Diagnosis

Aclarion secures U.S. patent for AI platform analyzing MRI data to identify painful spinal discs, expanding IP portfolio to 64 patents for chronic low back pain diagnosis technology.

This development represents a significant advancement in personalized medicine for chronic pain management, potentially affecting millions suffering from debilitating back pain. By securing patent protection for AI-driven analysis of magnetic resonance spectroscopy data, Aclarion creates a defensible technological advantage that could accelerate clinical adoption and standardization of objective pain assessment tools. For patients, this means potentially more accurate diagnoses, reduced unnecessary procedures, and improved surgical outcomes when intervention is needed. For healthcare systems, it offers a scalable solution to a pervasive problem that costs billions annually in treatment expenses and lost productivity. The technology's ability to provide reproducible, standardized outputs across different imaging systems addresses a critical barrier to widespread implementation of objective pain assessment tools in clinical practice.